1. Home
  2. XRTX vs TRNR Comparison

XRTX vs TRNR Comparison

Compare XRTX & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XRTX
  • TRNR
  • Stock Information
  • Founded
  • XRTX 2011
  • TRNR 2017
  • Country
  • XRTX Canada
  • TRNR United States
  • Employees
  • XRTX N/A
  • TRNR N/A
  • Industry
  • XRTX Pharmaceuticals and Biotechnology
  • TRNR Consumer Electronics/Appliances
  • Sector
  • XRTX Health Care
  • TRNR Technology
  • Exchange
  • XRTX Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • XRTX 3.0M
  • TRNR 3.3M
  • IPO Year
  • XRTX N/A
  • TRNR 2023
  • Fundamental
  • Price
  • XRTX $0.82
  • TRNR $1.00
  • Analyst Decision
  • XRTX
  • TRNR
  • Analyst Count
  • XRTX 0
  • TRNR 0
  • Target Price
  • XRTX N/A
  • TRNR N/A
  • AVG Volume (30 Days)
  • XRTX 45.7K
  • TRNR 3.8M
  • Earning Date
  • XRTX 11-15-2024
  • TRNR 03-31-2025
  • Dividend Yield
  • XRTX N/A
  • TRNR N/A
  • EPS Growth
  • XRTX N/A
  • TRNR N/A
  • EPS
  • XRTX N/A
  • TRNR N/A
  • Revenue
  • XRTX N/A
  • TRNR $3,180,000.00
  • Revenue This Year
  • XRTX N/A
  • TRNR $1,543.45
  • Revenue Next Year
  • XRTX N/A
  • TRNR $54.84
  • P/E Ratio
  • XRTX N/A
  • TRNR N/A
  • Revenue Growth
  • XRTX N/A
  • TRNR 226.82
  • 52 Week Low
  • XRTX $0.82
  • TRNR $0.86
  • 52 Week High
  • XRTX $7.00
  • TRNR $4,760.00
  • Technical
  • Relative Strength Index (RSI)
  • XRTX 34.99
  • TRNR 16.61
  • Support Level
  • XRTX $0.87
  • TRNR $1.14
  • Resistance Level
  • XRTX $0.97
  • TRNR $2.17
  • Average True Range (ATR)
  • XRTX 0.07
  • TRNR 0.26
  • MACD
  • XRTX 0.00
  • TRNR -0.02
  • Stochastic Oscillator
  • XRTX 0.00
  • TRNR 10.57

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: